1044. The Incidence and Severity of Drug interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients

BACKGROUND: Switching antiretroviral therapy (ART) in virally suppressed people with HIV (PWH) can simplify treatment, improve tolerability, and limit long-term toxicity. It can also influence the presence of drug interactions (DIs) in a positive or negative manner among patients receiving concomita...

Descripción completa

Detalles Bibliográficos
Autores principales: Schafer, Jason J, Pandit, Neha S, Cha, Agnes, Huesgen, Emily, Badowski, Melissa E, Sherman, Elizabeth, Cocohoba, Jennifer, Shimada, Ayako, Keith, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776504/
http://dx.doi.org/10.1093/ofid/ofaa439.1230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776504/
http://dx.doi.org/10.1093/ofid/ofaa439.1230

Ejemplares similares